High affinity anti-FRβ AML CAR T-cells demonstrate >50% cell killing in C30-FRβ expressing, THP1, and MV411 AML cell lines with minimal killing in HL60 at E:T ratios 5:1 and 1:1 (57). This evidence concerns the gene FOLR2 and acute myeloid leukemia.